top of page
Sneezing

Rebound COVID-19

We are now enrolling for a clinical trial evaluating the effectiveness of an oral treatment on individuals with rebound COVID-19.

A small number of people who have COVID-19 experience a return of signs/symptoms after initially feeling better, including those that have received treatment.

We have partnered with a sponsor to evaluate the effectiveness of an oral treatment on high-risk individuals who are experiencing rebound COVID-19 symptoms after initial treatment.

If you are interested in participating in this study or have questions about your eligibility, perform a self-check below and request a phone screen.

Download Study Flyer

Participant Enrollment Criteria
  • 12 years of age or older

  • Previous infection of COVID-19 with symptom alleviation followed by a worsening of signs/symptoms after completing a COVID-19 treatment.

  • One or more underlying medical condition associated with an increased risk of developing severe illness from COVID-19.

  • Additional criteria may apply


Participants Will Receive
  • Receive access to study related medical equipment and care


  • Receive compensation up to $820 and travel reimbursment.

Location and Time

  • All appointments are located at Eastside Research Associates in Redmond, WA

  • 8 in-clinic visits over the course of 24 weeks.

Join our patient list for future studies.

Please fill out the following form to join our patient list for current and future studies. A member of our study recruitment team will receive your information and reach out to you within one business day.

bottom of page